James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $572.33 ($5.8M) on 2026-04-20, disclosed to the SEC on 2026-04-21.
Scheduled sale ($5.8M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $572.33 | 880 | $504K | 8.7% |
| 2 | $573.45 | 1,543 | $885K | 15.3% |
| 3 | $574.09 | 442 | $254K | 4.4% |
| 4 | $575.41 | 1,010 | $581K | 10.1% |
| 5 | $576.37 | 1,398 | $806K | 13.9% |
| 6 | $577.27 | 687 |
| $397K |
| 6.9% |
| 7 | $578.90 | 500 | $289K | 5.0% |
| 8 | $579.86 | 340 | $197K | 3.4% |
| 9 | $581.66 | 488 | $284K | 4.9% |
| 10 | $582.47 | 983 | $573K | 9.9% |
| 11 | $583.55 | 1,009 | $589K | 10.2% |
| 12 | $584.49 | 482 | $282K | 4.9% |
| 13 | $585.36 | 238 | $139K | 2.4% |
| Total | $577.86 avg | 10,000 | $5.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |